3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
3
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Conditions
Warts
2
Virus Diseases
1
Skin Diseases, Viral
1
Skin Diseases, Infectious
1
Skin Diseases
1
Sexually Transmitted Diseases, Viral
1
Sexually Transmitted Diseases
1
Papillomavirus Infections
1
Condylomata Acuminata
1
Interventions
resiquimod
6
VP-102
2
N-phenylacetoaminomethylene-DL-p-nitrophenylalanine
2
Cantharidin
2
2-Propanol
2
methyl 5-aminolevulinate
1
ammonium trichloro(dioxoethylene-O,O'-)tellurate
1
Sugars
1
Photochemotherapy
1
Nitric Oxide
1
Maltose
1
Interferon-alpha
1
Imiquimod
1
Exercise
1
Equipment and Supplies
1
Cryotherapy
1
3-ingenyl angelate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Warts
×
Cantharidin
×
Clear all
NCT07457918
2026-05-05
COVE-4
Verrica Pharmaceuticals Inc.
Phase 3
Recruiting
600 enrolled
NCT03981822
2024-11-27
CARE-1
Verrica Pharmaceuticals Inc.
Phase 2
Completed
105 enrolled
24 charts